Literature DB >> 23283516

The evolutionary role of the IL-33/ST2 system in host immune defence.

Susanne Sattler1, Hermelijn H Smits, Damo Xu, Fang-Ping Huang.   

Abstract

Interleukin (IL)-33 is a recently identified pleiotropic cytokine, which can orchestrate complex innate and adaptive immune responses in immunity and disease. It has been characterized as a cytokine of the IL-1 family and affects a wide range of immune cells by signalling through its receptor ST2L. Accumulating evidence suggests a crucial role of IL-33/ST2 in inducing and modifying host immune responses against a variety of pathogens including parasites, bacteria, viruses and fungi as well as sterile insults of both endogenous and exogenous source. In this review, we endeavour to give a comprehensive overview of the current knowledge about the role of IL-33 and its receptor ST2 in host defence against infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23283516     DOI: 10.1007/s00005-012-0208-8

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  13 in total

1.  The role of ST2 and ST2 genetic variants in schistosomiasis.

Authors:  Xin Long; Michelle Daya; Jianping Zhao; Nicholas Rafaels; Huifang Liang; Joseph Potee; Monica Campbell; Bixiang Zhang; Maria Ilma Araujo; Ricardo R Oliveira; Rasika A Mathias; Li Gao; Ingo Ruczinski; Steve N Georas; Donata Vercelli; Terri H Beaty; Kathleen C Barnes; Xiaoping Chen; Qian Chen
Journal:  J Allergy Clin Immunol       Date:  2017-02-09       Impact factor: 10.793

2.  IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor.

Authors:  Sebastian Günther; Daniel Deredge; Amanda L Bowers; Alessandra Luchini; Daniel A Bonsor; Robert Beadenkopf; Lance Liotta; Patrick L Wintrode; Eric J Sundberg
Journal:  Immunity       Date:  2017-09-19       Impact factor: 31.745

3.  Perinatal Licensing of Thermogenesis by IL-33 and ST2.

Authors:  Justin I Odegaard; Min-Woo Lee; Yoshitaka Sogawa; Ambre M Bertholet; Richard M Locksley; David E Weinberg; Yuriy Kirichok; Rahul C Deo; Ajay Chawla
Journal:  Cell       Date:  2016-07-21       Impact factor: 41.582

4.  Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.

Authors:  Omar I Saadah; Sameer E Al-Harthi; Jamil A Al-Mughales; Yagoub Y Bin-Taleb; Raed S Baeshen
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

5.  Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis.

Authors:  Abdollah Jafarzadeh; Roya Mahdavi; Mitra Jamali; Hossain Hajghani; Maryam Nemati; Hossain-Ali Ebrahimi
Journal:  Oman Med J       Date:  2016-01

6.  Role of IL-33 and its receptor in T cell-mediated autoimmune diseases.

Authors:  Qing Zhao; Guangjie Chen
Journal:  Biomed Res Int       Date:  2014-06-16       Impact factor: 3.411

Review 7.  The role of IL-33 in host response to Candida albicans.

Authors:  C Rodríguez-Cerdeira; A Lopez-Bárcenas; B Sánchez-Blanco; R Arenas
Journal:  ScientificWorldJournal       Date:  2014-07-21

8.  Type II cytokines impair host defense against an intracellular fungal pathogen by amplifying macrophage generation of IL-33.

Authors:  A Verma; D N Kroetz; J L Tweedle; G S Deepe
Journal:  Mucosal Immunol       Date:  2014-08-13       Impact factor: 7.313

Review 9.  Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation.

Authors:  Ari B Molofsky; Adam K Savage; Richard M Locksley
Journal:  Immunity       Date:  2015-06-16       Impact factor: 31.745

10.  Detection of soluble ST2 in human follicular fluid and luteinized granulosa cells.

Authors:  Jennifer H Southcombe; Nathalie Lédée; Sophie Perrier d'Hauterive; Karen Turner; Tim Child; James V Snider; Christopher W G Redman; Ian L Sargent; Ingrid Granne
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.